α1-Adrenergic blocker. Prepn: H. Pahlicke, DE 905738 (1954 to Diwag), C.A. 52, 16294i (1958); A. Buzas et al., Bull. Soc. Chim. Fr. 1959, 839. Pharmacology: K. Greeff, H. J. Schümann, Arzneim.-Forsch. 3, 341 (1953); J. Mercier et al., Therapie 26, 785 (1971). Toxicology: J. Roquebert, J. Canellas, ibid. 775. α-Adrenergic antagonist activity: A. T. Birmingham, J. Szolcsanyi, J. Pharm. Pharmacol. 17, 449 (1965). α1-receptor selectivity: J. Roquebert et al., Arch. Int. Pharmacodyn. 266, 282 (1983). Series of articles on metabolism: K.-O. Vollmer et al., Eur. J. Drug Metab. Pharmacokinet. 10, 61, 71, 139 (1985). Clinical pharmacokinetics: P. Costa et al., J. Pharm. Sci. 82, 729, 968 (1993). HPLC determn of metabolites in plasma and urine: C. Marquer, F. Bressolle, J. Chromatogr. B 691, 389 (1997). Clinical trial in Raynaud's disease and chilblains: G. V. Jaffe, J. J. Grimshaw, Br. J. Clin. Pract. 34, 343 (1980). Review of clinical studies in ophthalmology: M. Wand, W. M. Grant, Surv. Ophthalmol. 25, 75-84 (1980). Clinical trial in impotence: P. Costa et al., J. Urol. 149, 301 (1993).
Vasodilator (peripheral). In treatment of male erectile dysfunction.
Vasodilator (Peripheral)